B86/100
Graded #4Partner
Invigor Medical
An established pharmacy operator with steady mid-market pricing and a broad catalog.
Visit Invigor Medical ↗Partner — we may earn a commission, at no cost to you. It never changes the grade.
- Semaglutide
- $199/mo
- Tirzepatide
- $339/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
Factor breakdown
Each of the six graded dimensions. See the methodology.
Cost value84/100
Dose & formulation84/100
Clinical oversight88/100
Labs & monitoring86/100
Fulfillment88/100
Contract terms90/100
Strengths
- Mid-market pricing on both molecules
- Long-running operator
Where it loses points
- No explicit states list
- Compounded only
Bottom line — Grade B
Best for: Patients who want GLP-1 care alongside a wider wellness program.
Pricing/verification reflect Invigor Medical's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Invigor Medical's site. Not medical advice; see our disclosure.